Concepedia

Author

Ana Gómez‐Rueda

Hospital Universitario Ramón y CajalORCID

Also Known As

A Gómez-Rueda, A. Gomez-Rueda, A. Gómez-Rueda, Ana Gómez-Rueda, Ana Gómez‐Rueda

15

Publications

270

Citations

6

H-Index

13

Concepts

All Affiliations

Hospital Universitario Ramón y CajalCentro de Investigación Biomédica en Red de CáncerHospital Universitario Virgen del RocíoSpanish National Cancer Research CentreHospital Universitario de La Princesa
AG

About

Ana Gómez‐Rueda is an author at Hospital Universitario Ramón y Cajal specializing in oncology, medicine, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

37

2

Pathology

2

2

37

3

Health Sciences

1

1

25

4

Immunology

1

1

12

5

Cancer Therapeutics

1

1

12

Ana Gómez‐Rueda

×

6

Publications

257

Citations

6

H-Index

YearCitations

Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping

J. Zugazagoitia, Inmaculada Ramos, José Trigo,

Annals of Oncology

2018

83

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti–PD-1 for patients with anti–PD-1–refractory tumors

Iván Márquez‐Rodas, Federico Longo, María E. Rodríguez-Ruiz,

Science Translational Medicine

2020

80

Canakinumab with and Without Pembrolizumab in Patients with Resectable Non-Small-Cell Lung Cancer: CANOPY-N Study Design

Pilar Garrido, Jean-Louis Pujol, Edward S. Kim,

Future Oncology

2021

46

Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance

Jon Zugazagoitia, Ana Gómez‐Rueda, Eloísa Jantus‐Lewintre,

Lung Cancer

2019

25

Sarcoidosis-like reactions in cancer patients treated with immune checkpoint inhibitors: experience in a Spanish hospital

Javier Torres-Jiménez, Jorge Esteban-Villarrubia, P. García‐Abellás,

Clinical & Translational Oncology

2021

12

Intratumoral BO-112, a double-stranded RNA (dsRNA), alone and in combination with systemic anti-PD-1 in solid tumors

Iván Márquez‐Rodas, Federico Longo, María E. Rodríguez-Ruiz,

Annals of Oncology

2018

11

Page 1